Vicriviroc Malate R)-Bicalutamide Anticancer Res

Anticancer Res

Epub 2016 Oct 24

26-trinoroleana-1(10)

for 1 day) potently induces a G1 arrest

4-dinitrophenyl)sulfonyl)piperazin-1-yl)quinoline

Vicriviroc Malate R)-Bicalutamide Anticancer ResVicriviroc, also known as SCH 417690, MK 7690 and SCH D, is a potent, orally active and selective CCR5 entry inhibitor of HIV 1 (IC50 = 0. 91 nM). Vicriviroc effectively inhibits the initial stages of the virus life cycle. Vicriviroc demonstrated synergistic anti HIV activity in combination with drugs from all other classes of approved antiretrovirals. Vicriviroc binds with higher affinity to CCR5 than SCH C. Functional assays, including inhibition of